0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Global Analytical Instrumentation Market Growth, Trends, Demand and Forecast to 2032Analytical Instrumentation Market The Analytical Instrumentation Market is witnessing steady expansion as industries increasingly depend on accurate measurement, material characterization, quality control, and advanced laboratory analysis. According to Maximize Market Research, the global Analytical Instrumentation Market was valued at USD 57.71 billion in 2025 and is...0 Комментарии 0 Поделились 616 Просмотры 0 предпросмотр
-
U.S. Analytical Instrumentation Market: Industry Trends and Growth OpportunitiesThe U.S. Analytical Instrumentation Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, U.S. Analytical Instrumentation Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and...0 Комментарии 0 Поделились 905 Просмотры 0 предпросмотр
-
Amide HPLC Column Market Growing at 4.4% CAGR Through 2034According to a new report from Intel Market Research, the global Amide HPLC Column market was valued at USD 151 million in 2025 and is projected to reach USD 203 million by 2034, growing at a CAGR of 4.4% during the forecast period (2026–2034). This growth is propelled by rising demand in pharmaceutical quality control, biotechnology research, food safety testing, environmental...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Global LC-MS Market Growing at 5.3% CAGR Through 2032According to a new report from Intel Market Research, the global LC-MS market was valued at USD 2.21 billion in 2024 and is projected to grow from USD 2.32 billion in 2025 to USD 3.15 billion by 2032, exhibiting a steady CAGR of 5.3% during the forecast period (2025–2032). This growth is driven by increasing R&D expenditure in the pharmaceutical and biotechnology sectors, stringent...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр